- Report
- April 2023
- 41 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- November 2023
- 189 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- February 2024
- 130 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- April 2024
- 182 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- February 2024
- 185 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- November 2023
- 190 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- November 2023
- 175 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- October 2023
- 190 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- October 2023
- 181 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- October 2023
- 178 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- October 2023
- 120 Pages
Global
From €4351EUR$4,500USD£3,737GBP
- Report
- January 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,446GBP
- Report
- January 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,446GBP
- Report
- January 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,446GBP
- Report
- August 2023
- 145 Pages
Global
From €3045EUR$3,150USD£2,616GBP
- Report
- December 2023
- 140 Pages
Global
From €4302EUR$4,450USD£3,695GBP
- Report
- September 2023
- 158 Pages
Global
From €2417EUR$2,500USD£2,076GBP
- Report
- December 2023
- 209 Pages
Global
From €3867EUR$4,000USD£3,322GBP
- Report
- November 2023
- 135 Pages
Global
From €3867EUR$4,000USD£3,322GBP
- Report
- September 2023
- 179 Pages
Global
From €3867EUR$4,000USD£3,322GBP
The Inhalers and Nebulisers market is a segment of the medical device industry that focuses on the development and production of devices used to deliver medication to the lungs. Inhalers and nebulisers are used to treat a variety of respiratory conditions, including asthma, COPD, and cystic fibrosis. Inhalers are handheld devices that deliver medication directly to the lungs in the form of a mist or aerosol. Nebulisers are larger devices that use a compressor to convert liquid medication into a mist that can be inhaled.
Inhalers and nebulisers are used by millions of people around the world, and the market is expected to grow in the coming years. Companies in the market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, and Teva Pharmaceuticals. These companies are involved in the development and production of inhalers and nebulisers, as well as the research and development of new treatments for respiratory conditions. Show Less Read more